Suppr超能文献

结核分枝杆菌临床分离株和自发突变体中对氨基水杨酸耐药性的分子遗传学

Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis.

作者信息

Mathys Vanessa, Wintjens René, Lefevre Philippe, Bertout Julie, Singhal Amit, Kiass Mehdi, Kurepina Natalia, Wang Xiao-Ming, Mathema Barun, Baulard Alain, Kreiswirth Barry N, Bifani Pablo

机构信息

Laboratory of Molecular Pathology of Tuberculosis, Pasteur Institute, Scientific Institute of Public Health, Brussels, Belgium.

出版信息

Antimicrob Agents Chemother. 2009 May;53(5):2100-9. doi: 10.1128/AAC.01197-08. Epub 2009 Feb 23.

Abstract

The emergence of Mycobacterium tuberculosis resistant to first-line antibiotics has renewed interest in second-line antitubercular agents. Here, we aimed to extend our understanding of the mechanisms underlying para-aminosalicylic acid (PAS) resistance by analysis of six genes of the folate metabolic pathway and biosynthesis of thymine nucleotides (thyA, dfrA, folC, folP1, folP2, and thyX) and three N-acetyltransferase genes [nhoA, aac(1), and aac(2)] among PAS-resistant clinical isolates and spontaneous mutants. Mutations in thyA were identified in only 37% of the clinical isolates and spontaneous mutants. Overall, 24 distinct mutations were identified in the thyA gene and 3 in the dfrA coding region. Based on structural bioinformatics techniques, the altered ThyA proteins were predicted to generate an unfolded or dysfunctional polypeptide. The MIC was determined by Bactec/Alert and dilution assay. Sixty-three percent of the PAS-resistant isolates had no mutations in the nine genes considered in this study, revealing that PAS resistance in M. tuberculosis involves mechanisms or targets other than those pertaining to the biosynthesis of thymine nucleotides. The alternative mechanism(s) or pathway(s) associated with PAS resistance appears to be PAS concentration dependent, in marked contrast to thyA-mutated PAS-resistant isolates.

摘要

对一线抗生素耐药的结核分枝杆菌的出现,重新引发了人们对二线抗结核药物的兴趣。在此,我们旨在通过分析耐对氨基水杨酸(PAS)的临床分离株和自发突变体中叶酸代谢途径及胸腺嘧啶核苷酸生物合成的六个基因(thyA、dfrA、folC、folP1、folP2和thyX)以及三个N - 乙酰转移酶基因[nhoA、aac(1)和aac(2)],来加深我们对PAS耐药机制的理解。仅在37%的临床分离株和自发突变体中鉴定出thyA突变。总体而言,在thyA基因中鉴定出24个不同的突变,在dfrA编码区鉴定出3个突变。基于结构生物信息学技术,预测改变后的ThyA蛋白会产生未折叠或功能失调的多肽。通过Bactec/Alert和稀释试验测定最低抑菌浓度(MIC)。63%的耐PAS分离株在本研究中所考虑的九个基因中没有突变,这表明结核分枝杆菌中的PAS耐药涉及除胸腺嘧啶核苷酸生物合成相关机制或靶点之外的其他机制或靶点。与PAS耐药相关的替代机制或途径似乎与PAS浓度有关,这与thyA突变的耐PAS分离株形成显著对比。

相似文献

1
Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis.
Antimicrob Agents Chemother. 2009 May;53(5):2100-9. doi: 10.1128/AAC.01197-08. Epub 2009 Feb 23.
4
The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria.
Mol Microbiol. 2004 Jul;53(1):275-82. doi: 10.1111/j.1365-2958.2004.04120.x.
8
dfrA thyA Double Deletion in para-Aminosalicylic Acid-Resistant Mycobacterium tuberculosis Beijing Strains.
Antimicrob Agents Chemother. 2016 May 23;60(6):3864-7. doi: 10.1128/AAC.00253-16. Print 2016 Jun.

引用本文的文献

1
Understanding flux switching in metabolic networks through an analysis of synthetic lethals.
NPJ Syst Biol Appl. 2024 Sep 17;10(1):104. doi: 10.1038/s41540-024-00426-5.
2
The T120P or M172V mutation on confers high level -aminosalicylic acid resistance in .
Emerg Microbes Infect. 2024 Dec;13(1):2374030. doi: 10.1080/22221751.2024.2374030. Epub 2024 Jul 24.
3
Competition between HPteGlu and HPtePAS Confers -Aminosalicylic Acid Resistance in .
Antibiotics (Basel). 2023 Dec 21;13(1):13. doi: 10.3390/antibiotics13010013.
6
Marine Macrolides to Tackle Antimicrobial Resistance of .
Mar Drugs. 2022 Nov 1;20(11):691. doi: 10.3390/md20110691.
8
Investigating and Modeling the Regulation of Extracellular Antibiotic Resistance Gene Bioavailability by Naturally Occurring Nanoparticles.
Environ Sci Technol. 2022 Nov 1;56(21):15044-15053. doi: 10.1021/acs.est.2c02878. Epub 2022 Jul 19.
10
Evolution and spread of a highly drug resistant strain of Mycobacterium tuberculosis in Papua New Guinea.
BMC Infect Dis. 2022 May 6;22(1):437. doi: 10.1186/s12879-022-07414-2.

本文引用的文献

1
Para-aminosalicylic acid in the treatment of tuberculosis.
Lancet. 1946 Jan 5;1(6384):15. doi: 10.1016/s0140-6736(46)91185-3.
3
Mutations of Bacteria from Virus Sensitivity to Virus Resistance.
Genetics. 1943 Nov;28(6):491-511. doi: 10.1093/genetics/28.6.491.
4
Molecular epidemiology of tuberculosis: current insights.
Clin Microbiol Rev. 2006 Oct;19(4):658-85. doi: 10.1128/CMR.00061-05.
6
Catalytic mechanism and structure of viral flavin-dependent thymidylate synthase ThyX.
J Biol Chem. 2006 Aug 18;281(33):24048-57. doi: 10.1074/jbc.M600745200. Epub 2006 May 17.
9
The treatment of tuberculosis in Sweden with para-aminosalicylic acid; a review.
Dis Chest. 1949 Dec;16(6):684-703, illust. doi: 10.1378/chest.16.6.684.
10
The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria.
Mol Microbiol. 2004 Jul;53(1):275-82. doi: 10.1111/j.1365-2958.2004.04120.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验